Pharmaceutical Training International is organizing the EU Biosimilar Registration and Marketing Requirements training in London, UK on 28-29 February 2012.
If you attend the 2-days training course, you will be able to:
– clarify the latest regulatory requirements for the registration of biosimilars
– examine EMA guidance on immunogenicity assessment of biotechnology derived therapeutic proteins
– learn how to prepare Module 3 of the CTD; special issues for biosimilars
– identify risk benefit conclusions and relevancy to clinical practice
If you are interested, the website of the training is: www.pti-global.co.uk/biosim